HelloBetter
Originally known as GET.ON, HelloBetter offers online courses and digital therapeutics (DTx) to prevent and treat mental illnesses. Said courses translate scientifically-validated cognitive behavioral therapy approaches into digestible content, covering eight major mental health issues ranging from depression, anxiety or insomnia to vaginismus and chronic pain. To ensure the quality of service, all psychologists in HelloBetter's service team have a Master's degree in psychology and are at least in the final stages of their training as psychotherapists or are already trained psychotherapists. In addition, all psychologists in the service team receive further training in online coaching.Select partners: Teva Pharmaceuticals, Barmer, SVLFG, Allianz.
Primary contact
Oranienburger Str. 86a
10178 Berlin
Germany
+49 (0)40 524733310
Oranienburger Str. 86a
10178 Berlin
Germany
+49 (0)40 524733310
Funding π°
Total β¬20M
Select investors Hevella Capital, HealthCap, Expon Capital, MassMutual Ventures, Sparrow Ventures
Key people π§βπ€βπ§
- Hannes KlΓΆpper - Co-founder & CEO
- Philip Ihde - Co-founder & COO
- Prof. Dr. David Daniel Ebert - Co-founder, Chief Scientific Officer & Managing Director
- Dr. Hanne Horvath - Co-founder & Chief Commercial Officer
- Dr. Elena Heber - Co-founder & Chief Clinical Officer
- Pierre Alexis Cantegril - Co-founder & Chief Product Officer
- Amit Gupta - Co-founder & CTO
- Saman Hashemian - CMO
Highlights β
- Evidence-based treatments: HelloBetter has the strongest evidence base globally, with a total of 33 randomized controlled trials published in peer-reviewed journals.
- Free for patients in Germany: In Germany, six of HelloBetter's therapy programmes are part of the standard of care and as such available to all adults for free as prescription digital therapeutics or DiGA.
- Eyes on the US market: In 2022, HelloBetter entered the US market with its HelloGina brand which offers a sexual wellness program for people with vaginismus.
- Cleared by the FDA: In April 2023, the company received Breakthrough Device Designation from the FDA for its DTx HelloBetter Panic. π
- Media love: HelloBetter has been featured in a few media outlets, including Der Spiegel, Frankfurter Allgemeine, Zeit Online, The Financial Times, Handelsblatt, and Bild, to name a few.
Video βΆοΈ
In the news π°
Awards & Recognitions π
- 2020 World Economic Forum Award
- 2020 Tech for Good: Digital Top 50
- 2019 World Summit Awards: Health & Well-Being
- 2018 EU Compass Good Practice
- 2018 Novartis Digital Health Award
- 2017 German Society of Behavioral Therapy Award
- 2017 EFPA Comenius Award
Quotes π¬
“
HelloBetter's achievements to date are impressive: the traction across partnerships with renowned insurance companies, a broad range of clinical trials showing extensive, high quality scientific evidence as well as an experienced, first class founding team have fully convinced us. We firmly believe that HelloBetter will bring significant benefits to patients, treating physicians and payers in the coming years.
— HealthCap partner Staffan Lindstrand π
Last update: May 8, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more

